Objective – To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity (SN), specificity (SP) and positive predictive value (PPV) than lipoproteins (LP), total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), and triglycerides (TGL) in assessing the risk of coronary heart disease (CHD). Methods – This is a transversal case-control study of 241 patients, who were divided into two groups: 1) 145 patients with CHD, and 2) 96 patients without coronary disease. A model of logistic regression to evaluate the relation between the LPs and CHD was developed in which variables with a p-alpha <0.1 were included. Results – Apo A-I levels were higher in the...
Emerging lipid risk factors for cardiovascular disease include lipoprotein remnants, lipoprotein (a)...
AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C...
Purpose of the study: to study the role of apoproteins of atherogenic and antiatherogenic lipoprotei...
Objective – To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity ...
OBJECTIVE: To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity (...
OBJECTIVE: To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity (...
OBJECTIVE: To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity (...
Coronary artery disease (CAD) is a major cause of morbidity and mortality in Western communities. Re...
Coronary artery disease (CAD) is a major cause of morbidity and mortality in modern society. Known r...
ported to be a better predictor of coronary artery disease than cholesterol indices. The objectives ...
BACKGROUND: To compare apolipoprotein B (apoB), non-high-density lipoprotein-cholesterol (non-HDL-c)...
INTRODUCTION: The Saudi population is renowned for their unhealthy diet and physical inactivity. OBJ...
Contains fulltext : 50695.pdf (publisher's version ) (Closed access)There is abund...
ported to be a better predictor of coronary artery disease than cholesterol indices. The objectives ...
PubMed ID: 17513206Objective: To investigate the relative roles of serum apolipoprotein (apo) B and ...
Emerging lipid risk factors for cardiovascular disease include lipoprotein remnants, lipoprotein (a)...
AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C...
Purpose of the study: to study the role of apoproteins of atherogenic and antiatherogenic lipoprotei...
Objective – To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity ...
OBJECTIVE: To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity (...
OBJECTIVE: To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity (...
OBJECTIVE: To evaluate whether apolipoproteins A-I (Apo A-I) and B (Apo B) have, higher ensitivity (...
Coronary artery disease (CAD) is a major cause of morbidity and mortality in Western communities. Re...
Coronary artery disease (CAD) is a major cause of morbidity and mortality in modern society. Known r...
ported to be a better predictor of coronary artery disease than cholesterol indices. The objectives ...
BACKGROUND: To compare apolipoprotein B (apoB), non-high-density lipoprotein-cholesterol (non-HDL-c)...
INTRODUCTION: The Saudi population is renowned for their unhealthy diet and physical inactivity. OBJ...
Contains fulltext : 50695.pdf (publisher's version ) (Closed access)There is abund...
ported to be a better predictor of coronary artery disease than cholesterol indices. The objectives ...
PubMed ID: 17513206Objective: To investigate the relative roles of serum apolipoprotein (apo) B and ...
Emerging lipid risk factors for cardiovascular disease include lipoprotein remnants, lipoprotein (a)...
AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C...
Purpose of the study: to study the role of apoproteins of atherogenic and antiatherogenic lipoprotei...